METTL14 and renal cell carcinoma: In renal cell carcinoma (RCC), METTL14 downregulates the expression of bromodomain PHD finger transcription factor (BPTF) to attenuate the oncogenic transcriptome, glycolytic reprogramming, and distal lung metastasis.387